Ligand validation:7AVN

LFA: EICOSANE

LFA is a Ligand Of Interest in 7AVN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
7AVN_LFA_B_304	29%	98%	0.146	0.841	0.17	0.1	-	-	0	80%	0.8
7AVN_LFA_A_302	28%	98%	0.146	0.834	0.14	0.15	-	-	0	80%	0.8
7AVN_LFA_B_303	26%	99%	0.141	0.873	0.12	0.11	-	-	0	50%	0.5
7AVN_LFA_B_301	21%	99%	0.146	0.864	0.12	0.12	-	-	0	40%	0.4
7AVN_LFA_A_309	19%	99%	0.169	0.776	0.11	0.13	-	-	1	90%	0.9
7AVN_LFA_A_303	18%	98%	0.184	0.858	0.13	0.14	-	-	0	50%	0.5
7AVN_LFA_B_306	16%	98%	0.169	0.774	0.12	0.17	-	-	1	80%	0.8
7AVN_LFA_A_305	16%	100%	0.188	0.866	0.09	0.1	-	-	0	40%	0.4
7AVN_LFA_B_305	16%	99%	0.206	0.902	0.1	0.11	-	-	0	30%	0.3
7AVN_LFA_A_304	15%	99%	0.164	0.853	0.11	0.13	-	-	0	30%	0.3
7AVN_LFA_B_311	13%	98%	0.168	0.823	0.14	0.14	-	-	0	35%	0.35
7AVN_LFA_A_311	13%	99%	0.116	0.776	0.11	0.13	-	-	0	30%	0.3
7AVN_LFA_B_309	12%	98%	0.138	0.777	0.13	0.13	-	-	0	40%	0.4
7AVN_LFA_B_312	12%	99%	0.147	0.766	0.11	0.11	-	-	1	50%	0.5
7AVN_LFA_B_310	12%	99%	0.164	0.807	0.12	0.09	-	-	0	35%	0.35
7AVN_LFA_A_306	11%	99%	0.17	0.76	0.12	0.08	-	-	0	60%	0.6
7AVN_LFA_B_307	10%	99%	0.167	0.742	0.1	0.1	-	-	2	60%	0.6
7AVN_LFA_B_302	9%	99%	0.202	0.793	0.12	0.09	-	-	2	40%	0.4
7AVN_LFA_B_308	7%	99%	0.162	0.748	0.09	0.14	-	-	2	30%	0.3
7AVN_LFA_A_310	7%	99%	0.153	0.726	0.13	0.08	-	-	2	30%	0.3
7AVN_LFA_A_301	6%	98%	0.213	0.74	0.16	0.1	-	-	0	50%	0.5
7AVN_LFA_A_307	6%	99%	0.158	0.676	0.12	0.12	-	-	0	50%	0.5
7AVN_LFA_B_313	5%	99%	0.191	0.729	0.11	0.12	-	-	2	30%	0.3
7AVN_LFA_A_308	5%	99%	0.218	0.7	0.13	0.1	-	-	0	50%	0.5
7AVN_LFA_A_313	2%	98%	0.246	0.646	0.15	0.11	-	-	1	30%	0.3
7AVN_LFA_A_312	1%	100%	0.321	0.551	0.08	0.1	-	-	1	65%	0.65
7Q37_LFA_A_309	34%	93%	0.174	0.882	0.24	0.26	-	-	0	85%	0.85
7AVP_LFA_A_303	33%	100%	0.142	0.838	0.09	0.07	-	-	1	90%	0.9
7AVO_LFA_B_306	33%	81%	0.154	0.866	0.29	0.52	-	-	4	80%	0.8
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	75%	0.75
8QLF_LFA_A_408	55%	100%	0.083	0.933	0.1	0.06	-	-	1	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	70%	0.7
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	70%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

7AVN

LFA: EICOSANE

LFA is a Ligand Of Interest in 7AVN designated by the RCSB